HTX-002
- Generic Name
- HTX-002
Evaluation of the Efficacy and Safety of Locally Administered HTX-011 for Postoperative Analgesia Following Bunionectomy
Phase 2
Completed
- Conditions
- Postoperative PainBunions
- Interventions
- Biological: Saline Placebo
- First Posted Date
- 2016-05-05
- Last Posted Date
- 2023-10-04
- Lead Sponsor
- Heron Therapeutics
- Target Recruit Count
- 430
- Registration Number
- NCT02762929
Evaluation of the Efficacy and Safety of HTX-011 for Postoperative Analgesia Following Abdominoplasty Surgery
Phase 2
Completed
- Conditions
- Postoperative Pain
- Interventions
- First Posted Date
- 2016-02-23
- Last Posted Date
- 2023-10-04
- Lead Sponsor
- Heron Therapeutics
- Target Recruit Count
- 277
- Registration Number
- NCT02689258
A Pilot Study to Investigate the Safety, Efficacy, Pharmacokinetics and Bioavailability of HTX-011, HTX-002, or HTX-009 Administered Via Injection and/or Topical Application Following Unilateral Open Inguinal Herniorrhaphy
Phase 2
Completed
- Conditions
- Postoperative Pain
- Interventions
- First Posted Date
- 2015-07-22
- Last Posted Date
- 2023-10-04
- Lead Sponsor
- Heron Therapeutics
- Target Recruit Count
- 463
- Registration Number
- NCT02504580
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath